Patients with early stage malignant pleural mesothelioma (MPM), a cancer that develops in the lining of the lungs, may be eligible for aggressive multi-modality therapy involving surgery, radiotherapy and chemotherapy. There are two main approaches, and controversy has existed about which approach is superior...
Source: http://www.medicalnewstoday.com/releases/243021.php
MICRON TECHNOLOGY INC WESTERN DIGITAL CORPORATION AGILENT TECHNOLOGIES, INC. AVAYA INC.
Tidak ada komentar:
Posting Komentar